Phase 2 N=45 Ruxolitinib in Seborrheic Dermatitis
Seborrheic Dermatitis
Primary: Number of Participants With Investigator Global Assessment of 0 or 1 at Week 4 — 20 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=25 A Silver Lining in the VAD Sky
LVAD (Left Ventricular Assist Device) Driveline Infection
Primary: Driveline Infection Rate — 0.51; 06.28 infections per 100 patient-month
Phase 4 N=87 Effects of Bromfenac on Macular Thickness After Phacoemulsification Surgery
Cataract · Cystoid Macular Edema After Phacoemulsification
Primary: Change in Macular Thickness From Baseline to 6 Weeks Postoperatively After Cataract Surgery — 252.6; 253.1 Microns
N/A N=170 Ceramic-on-Ceramic (COC) 36mm Acetabular Bearing Insert Post Approval Study-New Subjects (COC36mmPAS)
Non-inflammatory Degenerative Joint Disease · Osteoarthritis · Avascular Necrosis
Primary: Post-Operative 5-Year Device Survivorship — 95.3 Percentage of implants
N/A N=960 A Patient-centered Intervention Using Technology to Reduce Colorectal Cancer Disparities in Primary Care
Colo-rectal Cancer
Primary: Intention to Screen for Colorectal Cancer (CRC) — 4.33; 4.45 units on a scale
Phase 1 N=35 Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety Phenotype
Obesity · Healthy
Primary: Glucagon-Like Peptide-1 (GLP-1) — 18; 17 Participants
N/A N=4,451 Awareness Enhancing Interventions
Research Awareness
Primary: Recruitment Yield — 13; 33; 37 participants — p=0.2345
N/A N=160 Examining Transcutaneous Vagal Nerve Stimulation as a Facilitator of Social Bonding
Vagus Nerve Stimulation
Primary: Self-reported Positive Affect — 5.89; 5.69 units on a scale
Phase 2 N=15 A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity
Non Hodgkin Lymphoma · Refractory Non-Hodgkin Lymphoma · Relapsed Non Hodgkin Lymphoma
Primary: Rate of Neurotoxicity as Per CTCAE v4.03 Criteria — 3; 2; 5; 1 Participants
N/A N=12 A Non-significant Risk Clinical Study of Therapeutic Ultrasound for Patients With Diabetic Foot Ulcers.
Diabetic Foot Ulcer · Peripheral Arterial Disease · Wound; Foot
Primary: Transcutaneous Oxygen Pressure (TcPO2) — 50.96 mmHg
N/A N=41 Culturally-Responsive Curriculum for Caregivers With Children at Autism Likelihood
Autism · Development Delay
Primary: Staff Training Feedback Survey of Implementation Properties (Self-report)
N/A N=20 Comparing Post-operative Analgesia After (PECS II) Block and (ESPB) in Modified Radical Mastectomy
Anaesthesia
Primary: Post-operative Pain Severity Assessed by Visual Analogue Scale Immediately Postoperative on Admission to the Post Anesthesia Care Unit. — 0.4; 0.9 score on a scale
Phase 2 N=13 Cheese Consumption and Human Microvascular Function
Microvascular Dysfunction
Primary: Microvascular Reactivity to Acetylcholine — -4.90; -4.82; -5.44; -3.21 log (M)
Phase 4 N=19 Truncal Ultrasound Guided Regional Anesthesia for Implantation and Revision of Automatic Implantable Cardioverter Defibrillators (AICDs) and Pacemakers in Pediatric Patients
Analgesia After Pacemaker · AICDS Implantation Pediatrics
Primary: Total Narcotic Dose in Milligram Morphine Equivalents (MME) Per Kilogram — 0.035; 0.008 MME per kg
N/A N=24 Phase I Assessment of Hypertonic Saline in Moderate to Severe Asthmatics
Moderate to Severe Asthma
Primary: Change in MCC From Baseline to 7% Post Hypertonic Saline Inhalation — 29.9 percent clearance — p=<0.001